Viewing nowOmethon S Tablet 20 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Dongku Bio Pharmaceutical Co., Ltd.

MFDS item code 201603678 · Approved 2016.06.21 · Insurance code 657306890
Treatment and prevention of gastroesophageal reflux disease, gastroduodenal ulcers and gastrointestinal symptoms, and Zollinger-Ellison syndrome
This medication is used to treat gastroesophageal reflux disease and erosive reflux esophagitis, as well as to provide long-term maintenance therapy to prevent recurrence in esophagitis patients. It also helps relieve symptoms of gastroesophageal reflux disease without esophagitis. It is used in combination with antibiotics for the treatment of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection and to prevent recurrence. Additionally, it is effective as a short-term therapy to treat upper gastrointestinal symptoms such as pain, discomfort, and burning sensation caused by the consumption of non-steroidal anti-inflammatory drugs. It is used to treat gastric ulcers in patients requiring continuous administration of non-steroidal anti-inflammatory drugs and to prevent gastric and duodenal ulcers. Finally, it is used in the treatment of Zollinger-Ellison syndrome and for maintaining prevention of re-bleeding from gastric or duodenal ulcers. Thus, it is widely used for the treatment and prevention of various gastrointestinal disorders.
Swallow this medicine with a liquid such as water; do not chew or crush it. 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed dosing to control recurring symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical studies lasting longer than 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment duration is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should thereafter be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and taken twice daily. 6) Maintenance therapy after intravenous treatment to induce prevention of rebleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks after intravenous treatment to induce prevention of rebleeding from gastric or duodenal ulcers. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience with administration to patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine must not exceed 20 mg. 6. Older adults No dose adjustment is necessary.
Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. Children under 12 years of age There is no experience with administration of this medicine to children under 12 years of age.
This drug should not be used in patients who have had allergic reactions to certain components or benzimidazole derivatives. It is also necessary to exercise caution when using this drug in combination for patients with allergies to penicillin-based antibiotics or macrolide antibiotics. Consultation with a doctor is needed because taking this drug with certain heart-related medications or antiviral agents may result in side effects or drug interactions. It is safest for nursing mothers to refrain from taking this drug. Patients with a history of heart disease or myocardial infarction are also advised not to use this drug. Regular checking for adverse reactions or health status is important when using this drug for long periods. Various side effects may occur, including insomnia, headache, dizziness, gastrointestinal disturbances, skin rashes, muscle pain, so if symptoms are severe, tell your doctor. Particularly, if muscle pain or weakness worsens, serious conditions such as rhabdomyolysis may occur, requiring careful monitoring. This drug can increase the risk of infections such as diarrhea by suppressing gastric acid secretion, which may promote bacterial growth in the stomach. Long-term use may lead to hypomagnesemia, so periodic checks of magnesium levels are necessary. Due to potential drug interactions, especially when used in combination with anticoagulants, antidepressants, anticonvulsants, antiviral agents, etc., consultation with medical staff is essential. There is limited safety data regarding usage during pregnancy, so caution is advised when administering during pregnancy, and it is recommended not to take while nursing. In case of overdose, as there is no specific antidote, immediate medical treatment is required, and it should be kept out of the reach of children.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, acute generalized exanthematous pustulosis, eosinophilia and systemic symptoms with drug reaction, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, hyperhidrosis, Clostridium difficile-associated diarrhea, abdominal distension, allergic reactions, back pain, chest pain, substernal chest pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disturbances, frequent bowel movements, gastritis, gastrointestinal bleeding, hiccups, melena, oral disturbances, pharyngeal disturbances, rectal disturbances, gastrointestinal symptoms, increased serum gastrin, tongue disturbances, glossitis, ulcerative stomatitis, ear pain, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorders, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, abnormal olfaction, taste loss, dysgeusia, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infections, hematuria, micturition frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal pigmentation, hernia, systemic lupus erythematosus, discoid lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to avoid exposure to air or moisture, and it is safe to store at room temperature between 1 degree and 30 degrees Celsius.
Pink round film-coated tablet
28 tablets/Alu-Alu packaging (14 tablets/Alu-Alu x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Dongku Bio Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.